{"id":9026,"date":"2025-12-28T22:13:18","date_gmt":"2025-12-28T13:13:18","guid":{"rendered":"https:\/\/japanir.jp\/en\/company\/company-4553\/"},"modified":"2026-08-16T12:09:57","modified_gmt":"2026-08-16T03:09:57","slug":"company-4553","status":"publish","type":"company","link":"https:\/\/japanir.jp\/en\/company\/company-4553\/","title":{"rendered":"TOWA PHARMACEUTICAL CO"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","meta":{"Ticker":"4553","DATE":"2025-12-26","longName":"Towa Pharmaceutical Co., Ltd.","company_name_ja":"","fullTimeEmployees":4923,"address":"","phone":"","website":"https:\/\/www.towayakuhin.co.jp","industry":"Drug Manufacturers - Specialty & Generic","sector":"Healthcare","regularMarketPrice":3725,"financialCurrency":"","marketCap":183373,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":106.66,"epsForward":0,"bookValue":0,"totalRevenue":273710000000,"OperatingIncome":23103000000,"operatingMargins":8.4399999999999995,"NetIncome":5250000000,"profitMargins":1.9199999999999999,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":2.9500000000000002,"recommendationMean":1.5,"recommendationKey":"strong_buy","targetMeanPrice":5266.6665000000003,"numberOfAnalystOpinions":6,"analyst_earnings_data":"{\"success\": true, \"fetched_at\": \"2026-08-01T04:46:32.726589\", \"ticker\": \"4553\", \"ticker_full\": \"4553.T\", \"company_name\": \"TOWA PHARMACEUTICAL CO\", \"analyst_recommendations\": {\"has_data\": true, \"period\": \"3\", \"strong_buy\": 0, \"buy\": 4, \"hold\": 2, \"sell\": 0, \"strong_sell\": 0, \"total_analysts\": 6, \"recommendation_key\": \"strong_buy\", \"recommendation_mean\": 1.5}, \"target_prices\": {\"has_data\": true, \"current\": 4005.0, \"high\": 5900.0, \"low\": 4500.0, \"mean\": 5266.6665, \"median\": 5450.0}, \"earnings_dates\": {\"has_data\": true, \"next_earnings\": {\"date\": \"2026-08-06\", \"eps_estimate\": 63.46, \"eps_actual\": null, \"surprise_pct\": null}, \"future_count\": 1, \"past_earnings\": [{\"date\": \"2026-05-13\", \"eps_estimate\": 107.04, \"eps_actual\": -240.35, \"surprise_pct\": -324.54}, {\"date\": \"2026-02-12\", \"eps_estimate\": 73.56, \"eps_actual\": 180.15, \"surprise_pct\": 144.9}, {\"date\": \"2025-11-10\", \"eps_estimate\": 62.02, \"eps_actual\": 115.8, \"surprise_pct\": 86.71}, {\"date\": \"2025-08-06\", \"eps_estimate\": 63.46, \"eps_actual\": 51.06, \"surprise_pct\": -19.54}, {\"date\": \"2025-05-15\", \"eps_estimate\": 113.89, \"eps_actual\": 88.61, \"surprise_pct\": -22.19}]}, \"shareholders\": {\"has_data\": true, \"insider_pct\": 48.2, \"institution_pct\": 22.64, \"major_holders\": [{\"label\": \"\", \"value\": 48.2}, {\"label\": \"\", \"value\": 22.64}, {\"label\": \"\", \"value\": 43.7}, {\"label\": \"\", \"value\": 75.0}], \"institutional_holders\": [{\"holder\": \"Brown Capital Mgmt Mutual Fd.s-Brown Capital Mgmt Intl Small Company F\", \"shares\": 1920782, \"date_reported\": \"2026-03-31\", \"pct_held\": 3.73, \"pct_change\": -19.98, \"value\": 7692731910}, {\"holder\": \"VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund\", \"shares\": 355182, \"date_reported\": \"2026-04-30\", \"pct_held\": 0.69, \"pct_change\": 0.0, \"value\": 1422503910}, {\"holder\": \"American Century ETF Trust-Avantis International Small Cap Value ETF\", \"shares\": 267000, \"date_reported\": \"2026-06-30\", \"pct_held\": 0.52, \"pct_change\": -15.37, \"value\": 1069335000}, {\"holder\": \"VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund\", \"shares\": 231862, \"date_reported\": \"2026-03-31\", \"pct_held\": 0.45, \"pct_change\": 2.84, \"value\": 928607310}, {\"holder\": \"DFA INVESTMENT TRUST CO-The Japanese Small Company Series\", \"shares\": 161600, \"date_reported\": \"2026-04-30\", \"pct_held\": 0.31, \"pct_change\": 0.0, \"value\": 647208000}, {\"holder\": \"iShares Trust-iShares Core MSCI EAFE ETF\", \"shares\": 158000, \"date_reported\": \"2026-06-30\", \"pct_held\": 0.31, \"pct_change\": 15.08, \"value\": 632790000}, {\"holder\": \"DFA INVESTMENT DIMENSIONS GROUP INC-DFA Intl Small Cap Value PORT.\", \"shares\": 154340, \"date_reported\": \"2026-04-30\", \"pct_held\": 0.3, \"pct_change\": 0.0, \"value\": 618131700}, {\"holder\": \"DFA INVESTMENT DIMENSIONS GROUP INC-Intl Core Eqy. 2 PORT.\", \"shares\": 151500, \"date_reported\": \"2026-04-30\", \"pct_held\": 0.29, \"pct_change\": 9.23, \"value\": 606757500}, {\"holder\": \"Dimensional ETF Trust-Dimensional International Small Cap Value ETF\", \"shares\": 133400, \"date_reported\": \"2026-04-30\", \"pct_held\": 0.26, \"pct_change\": 1.14, \"value\": 534267000}, {\"holder\": \"Old Westbury Funds Inc-Old Westbury Small & Mid Cap Strategies Fund\", \"shares\": 126900, \"date_reported\": \"2026-04-30\", \"pct_held\": 0.25, \"pct_change\": 0.0, \"value\": 508234500}], \"mutualfund_holders\": []}}","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"Towa Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sale ethical drugs in Japan. The company operates through two segments; Domestic and Overseas. It provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products, as well as provide formulations from tablets, capsules, injectable, patches, eye drops, and other products. The company also offers IT service related to healthcare; disease risk testing services; and sale of quasi drugs. In addition, it is involved in research and development and production of active pharmaceutical ingredients, intermediates, and support business; and planning, development and OEM manufacturing of health foods, pharmaceuticals, general foods, and other miscellaneous merchandizes. Towa Pharmaceutical Co., Ltd. was founded in 1951 and is headquartered in Kadoma, Japan.","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":40,"get_dividend_history_year2":80,"get_dividend_history_year3":60,"get_dividend_history_year4":60,"get_dividend_history_year5":63,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"financial_data":"","detailed_financial_data":"{\"success\": true, \"fetched_at\": \"2026-08-16T02:49:34.927015\", \"ticker\": \"4553\", \"ticker_full\": \"4553.T\", \"company_name\": \"TOWA PHARMACEUTICAL CO\", \"company_info\": {\"name_en\": \"TOWA PHARMACEUTICAL CO\", \"long_name\": \"Towa Pharmaceutical Co., Ltd.\", \"sector\": \"Healthcare\", \"industry\": \"Drug Manufacturers - Specialty & Generic\", \"website\": \"https:\/\/www.towayakuhin.co.jp\", \"employees\": 4923, \"country\": \"Japan\", \"city\": \"Kadoma\", \"address\": \"2-11, Shinbashi-cho\", \"description\": \"Towa Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sale ethical drugs in Japan. The company operates through two segments; Domestic and Overseas. It provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products, as well as provide formulations from tablets, capsules, injectable, patches, eye drops, and other products. The company also offers IT service related to healthcare; disease risk testing services; and sale of quasi drugs. In addition, it is involved in research and development and production of active pharmaceutical ingredients, intermediates, and support business; and planning, development and OEM manufacturing of health foods, pharmaceuticals, general foods, and other miscellaneous merchandizes. Towa Pharmaceutical Co., Ltd. was founded in 1951 and is headquartered in Kadoma, Japan.\"}, \"price_trend\": {\"ma_5\": {\"ma_value\": 3787.0, \"deviation\": 0.21, \"trend\": \"up\"}, \"ma_25\": {\"ma_value\": 4022.2, \"deviation\": -5.65, \"trend\": \"down\"}, \"ma_75\": {\"ma_value\": 3895.4, \"deviation\": -2.58, \"trend\": \"down\"}, \"ma_200\": {\"ma_value\": 3733.21, \"deviation\": 1.66, \"trend\": \"up\"}}, \"financials\": {\"years\": [{\"year\": 2026, \"revenue\": 273710000000.0, \"revenue_fmt\": \"\u00a52737\u5104\", \"gross_profit\": 99104000000.0, \"gross_profit_fmt\": \"\u00a5991\u5104\", \"operating_income\": 23103000000.0, \"operating_income_fmt\": \"\u00a5231\u5104\", \"ebit\": 15426000000.0, \"ebit_fmt\": \"\u00a5154\u5104\", \"net_income\": 5250000000.0, \"net_income_fmt\": \"\u00a552\u5104\", \"eps\": 106.66, \"operating_margin\": 8.44, \"total_assets\": 475290000000.0, \"total_assets_fmt\": \"\u00a54753\u5104\", \"total_equity\": 178103000000.0, \"total_equity_fmt\": \"\u00a51781\u5104\", \"total_debt\": 226735000000.0, \"total_debt_fmt\": \"\u00a52267\u5104\", \"total_cash\": 45306000000.0, \"total_cash_fmt\": \"\u00a5453\u5104\", \"equity_ratio\": 37.47, \"de_ratio\": 1.27, \"current_ratio\": 2.76, \"operating_cf\": 30429000000.0, \"operating_cf_fmt\": \"\u00a5304\u5104\", \"investing_cf\": -25660000000.0, \"investing_cf_fmt\": \"-\u00a5257\u5104\", \"financing_cf\": -6828000000.0, \"financing_cf_fmt\": \"-\u00a568\u5104\", \"free_cf\": 6301000000.0, \"free_cf_fmt\": \"\u00a563\u5104\", \"net_margin\": 1.92, \"roe\": 2.95, \"roa\": 1.1}, {\"year\": 2025, \"revenue\": 259594000000.0, \"revenue_fmt\": \"\u00a52596\u5104\", \"gross_profit\": 94729000000.0, \"gross_profit_fmt\": \"\u00a5947\u5104\", \"operating_income\": 23243000000.0, \"operating_income_fmt\": \"\u00a5232\u5104\", \"ebit\": 27957000000.0, \"ebit_fmt\": \"\u00a5280\u5104\", \"net_income\": 18986000000.0, \"net_income_fmt\": \"\u00a5190\u5104\", \"eps\": 385.71, \"operating_margin\": 8.95, \"total_assets\": 470823000000.0, \"total_assets_fmt\": \"\u00a54708\u5104\", \"total_equity\": 171624000000.0, \"total_equity_fmt\": \"\u00a51716\u5104\", \"total_debt\": 230983000000.0, \"total_debt_fmt\": \"\u00a52310\u5104\", \"total_cash\": 45471000000.0, \"total_cash_fmt\": \"\u00a5455\u5104\", \"equity_ratio\": 36.45, \"de_ratio\": 1.35, \"current_ratio\": 2.81, \"operating_cf\": 23401000000.0, \"operating_cf_fmt\": \"\u00a5234\u5104\", \"investing_cf\": -31287000000.0, \"investing_cf_fmt\": \"-\u00a5313\u5104\", \"financing_cf\": 21567000000.0, \"financing_cf_fmt\": \"\u00a5216\u5104\", \"free_cf\": -7822000000.0, \"free_cf_fmt\": \"-\u00a578\u5104\", \"net_margin\": 7.31, \"roe\": 11.06, \"roa\": 4.03}, {\"year\": 2024, \"revenue\": 227934000000.0, \"revenue_fmt\": \"\u00a52279\u5104\", \"gross_profit\": 81383000000.0, \"gross_profit_fmt\": \"\u00a5814\u5104\", \"operating_income\": 17648000000.0, \"operating_income_fmt\": \"\u00a5176\u5104\", \"ebit\": 25406000000.0, \"ebit_fmt\": \"\u00a5254\u5104\", \"net_income\": 16173000000.0, \"net_income_fmt\": \"\u00a5162\u5104\", \"eps\": 328.59, \"operating_margin\": 7.74, \"total_assets\": 430653000000.0, \"total_assets_fmt\": \"\u00a54307\u5104\", \"total_equity\": 155892000000.0, \"total_equity_fmt\": \"\u00a51559\u5104\", \"total_debt\": 203308000000.0, \"total_debt_fmt\": \"\u00a52033\u5104\", \"total_cash\": 29650000000.0, \"total_cash_fmt\": \"\u00a5296\u5104\", \"equity_ratio\": 36.2, \"de_ratio\": 1.3, \"current_ratio\": 2.72, \"operating_cf\": 8212000000.0, \"operating_cf_fmt\": \"\u00a582\u5104\", \"investing_cf\": -40394000000.0, \"investing_cf_fmt\": \"-\u00a5404\u5104\", \"financing_cf\": 35407000000.0, \"financing_cf_fmt\": \"\u00a5354\u5104\", \"free_cf\": -31113000000.0, \"free_cf_fmt\": \"-\u00a5311\u5104\", \"net_margin\": 7.1, \"roe\": 10.37, \"roa\": 3.76}, {\"year\": 2023, \"revenue\": 208859000000.0, \"revenue_fmt\": \"\u00a52089\u5104\", \"gross_profit\": 72713000000.0, \"gross_profit_fmt\": \"\u00a5727\u5104\", \"operating_income\": 5514000000.0, \"operating_income_fmt\": \"\u00a555\u5104\", \"ebit\": 5240000000.0, \"ebit_fmt\": \"\u00a552\u5104\", \"net_income\": 2201000000.0, \"net_income_fmt\": \"\u00a522\u5104\", \"eps\": 44.72, \"operating_margin\": 2.64, \"total_assets\": 371347000000.0, \"total_assets_fmt\": \"\u00a53713\u5104\", \"total_equity\": 136893000000.0, \"total_equity_fmt\": \"\u00a51369\u5104\", \"total_debt\": 161518000000.0, \"total_debt_fmt\": \"\u00a51615\u5104\", \"total_cash\": 24257000000.0, \"total_cash_fmt\": \"\u00a5243\u5104\", \"equity_ratio\": 36.86, \"de_ratio\": 1.18, \"current_ratio\": 2.33, \"operating_cf\": 2544000000.0, \"operating_cf_fmt\": \"\u00a525\u5104\", \"investing_cf\": -30284000000.0, \"investing_cf_fmt\": \"-\u00a5303\u5104\", \"financing_cf\": 17481000000.0, \"financing_cf_fmt\": \"\u00a5175\u5104\", \"free_cf\": -27925000000.0, \"free_cf_fmt\": \"-\u00a5279\u5104\", \"net_margin\": 1.05, \"roe\": 1.61, \"roa\": 0.59}], \"has_data\": true}, \"dividends\": {\"history\": [{\"year\": 2022, \"amount\": 63.0}, {\"year\": 2023, \"amount\": 60.0}, {\"year\": 2024, \"amount\": 60.0}, {\"year\": 2025, \"amount\": 80.0}, {\"year\": 2026, \"amount\": 40.0}], \"latest\": 40.0, \"has_data\": true}}","ma_5_value":0,"ma_5_deviation":0,"ma_5_trend":"","ma_25_value":0,"ma_25_deviation":0,"ma_25_trend":"","ma_75_value":0,"ma_75_deviation":0,"ma_75_trend":"","ma_200_value":0,"ma_200_deviation":0,"ma_200_trend":"","previousClose":0,"open":0,"dayHigh":0,"dayLow":0,"volume":0,"averageVolume":0,"revenueGrowth":0},"sector":[],"class_list":["post-9026","company","type-company","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>TOWA PHARMACEUTICAL CO - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-4553\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4553\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-4553\/\",\"name\":\"TOWA PHARMACEUTICAL CO - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2025-12-28T13:13:18+00:00\",\"dateModified\":\"2026-08-16T03:09:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4553\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-4553\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4553\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TOWA PHARMACEUTICAL CO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TOWA PHARMACEUTICAL CO - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-4553\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-4553\/","url":"https:\/\/japanir.jp\/en\/company\/company-4553\/","name":"TOWA PHARMACEUTICAL CO - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2025-12-28T13:13:18+00:00","dateModified":"2026-08-16T03:09:57+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-4553\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-4553\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-4553\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"TOWA PHARMACEUTICAL CO"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company\/9026","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/company"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=9026"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=9026"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}